Blog 07 via RxSense Specialty drug spending contributes the largest share to rising healthcare costs. To make matters worse, in the case of rheumatoid arthritis, most patients will, over time, become refractory to these specialty biologics. In some cases,...
Blog 06 Q&A with Erin Connolly-Strong PhD, Head Medical Affairs Scipher Medicine via BiopharmaDive Multiple classes of drugs exist for treating rheumatoid arthritis (RA) patients. But close to 90% of patients failing methotrexate are prescribed the world’s largest...
Blog 4 Researchers at Scipher Medicine have combined proprietary data and artificial intelligence to predict a patient’s response to costly biologics. Slava Akmaev, Ph.D., Scipher Chief Technology Officer and Head of Therapeutics describes the implications of their...
Blog 03 Bret S. Stetka, MD Medicine is often a guessing game. Doctors frequently prescribe medications that, while effective across the collective population, may not work for specific individuals. This is why so many clinicians are studying and advocating for...
Blog 02 Bret S. Stetka, MD A recent review published in JAMA reported that the annual monetary waste in the U.S. healthcare system is approaching a staggering 1 trillion dollars. Over half of this is due to patients being prescribed drugs that they don’t actually...
Blog 01 Bret S. Stetka, MD The human genome contains over 20,000 genes. And every single one of these encodes for a protein that has some function in our body. But just as crucial to both health and disease is how these proteins interact with each other: how they...
